|
MBIP expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.4547999471759E-09 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.44799999663081E-09 |
| Normal-vs-Stage2 |
2.38160000000098E-05 |
| Normal-vs-Stage3 |
2.10250000000078E-05 |
| Normal-vs-Stage4 |
1.715490E-03 |
| Stage1-vs-Stage2 |
9.932600E-01 |
| Stage1-vs-Stage3 |
3.883400E-01 |
| Stage1-vs-Stage4 |
6.552800E-01 |
| Stage2-vs-Stage3 |
5.333000E-01 |
| Stage2-vs-Stage4 |
6.319000E-01 |
| Stage3-vs-Stage4 |
9.683000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.32950009177091E-10 |
| Normal-vs-AfricanAmerican |
2.48149999999558E-05 |
| Normal-vs-Asian |
1.764140E-02 |
| Caucasian-vs-AfricanAmerican |
1.393810E-01 |
| Caucasian-vs-Asian |
6.401400E-01 |
| AfricanAmerican-vs-Asian |
9.607800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.45659961659339E-10 |
| Normal-vs-Female |
5.635200E-04 |
| Male-vs-Female |
7.865600E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.22410000000539E-05 |
| Normal-vs-Extreme_Weight |
6.30629992670606E-10 |
| Normal-vs-Obese |
1.417560E-04 |
| Normal-vs-Extreme_Obese |
6.1494999999967E-05 |
| Normal_Weight-vs-Extreme_Weight |
4.297200E-01 |
| Normal_Weight-vs-Obese |
4.387000E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.247400E-01 |
| Extreme_Weight-vs-Obese |
6.245800E-02 |
| Extreme_Weight-vs-Extreme_Obese |
9.484200E-01 |
| Obese-vs-Extreme_Obese |
4.009600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.025200E-01 |
| Normal-vs-Age(41-60Yrs) |
1.31670000003137E-06 |
| Normal-vs-Age(61-80Yrs) |
1.30340183090993E-11 |
| Normal-vs-Age(81-100Yrs) |
5.57150000000117E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.938000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.095600E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.809630E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.181700E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.418200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.686600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.90439997105329E-09 |
| Normal-VS-Type2 PRCC |
4.08640010718386E-10 |
| Normal-VS-KIRP CIMP |
6.153800E-01 |
| Normal-VS-Unclassified PRCC |
1.917759999992E-05 |
| Type1 PRCC-VS-Type2 PRCC |
2.658800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.559380E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
9.653400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
9.357600E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
4.632200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
7.654100E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.35199962336685E-10 |
| Normal-vs-N1 |
5.820300E-02 |
| Normal-vs-N2 |
1.59916999999954E-05 |
| N0-vs-N1 |
1.399580E-03 |
| N0-vs-N2 |
2.151800E-01 |
| N1-vs-N2 |
3.102100E-02 |
|
|
